Skip header navigation

University of Stirling

×

Article

Lipid remodelling and an altered membrane-associated proteome may drive the differential effects of EPA and DHA treatment on skeletal muscle glucose uptake and protein accretion

Citation
Jeromson S, Mackenzie I, Doherty MK, Whitfield PD, Bell JG, Dick JR, Shaw A, Rao F, Ashcroft SP, Philp A, Galloway SD, Gallagher IJ & Hamilton DL (2018) Lipid remodelling and an altered membrane-associated proteome may drive the differential effects of EPA and DHA treatment on skeletal muscle glucose uptake and protein accretion. American Journal of Physiology - Endocrinology and Metabolism, 314 (6), pp. E605-E619. https://doi.org/10.1152/ajpendo.00438.2015

Abstract
In striated muscle, EPA and DHA have differential effects on the metabolism of glucose and differential effects on the metabolism of protein. We have shown that, despite similar incorporation, treatment of C2C12 myotubes (CM) with EPA but not DHA improves glucose uptake and protein accretion. We hypothesized that these differential effects of EPA and DHA may be due to divergent shifts in lipidomic profiles leading to altered proteomic profiles. We therefore carried out an assessment on the impact of treating CM with EPA and DHA on lipidomic and proteomic profiles. FAME analysis revealed that both EPA and DHA led to similar but substantial changes in fatty acid profiles. Global lipidomic analysis showed that EPA and DHA induced large alterations in the cellular lipid profiles and in particular, the phospholipid classes. Subsequent targeted analysis confirmed that the most differentially regulated species were phosphatidylcholines and phosphatidylethanolamines containing long chain fatty acids with 5 (EPA treatment) or 6 (DHA treatment) double bonds. As these are typically membrane associated lipid species we hypothesized that these treatments differentially altered the membrane-associated proteome. SILAC based proteomics of the membrane fraction revealed significant divergence in the effects of EPA and DHA on the membrane associated proteome. We conclude that the EPA specific increase in polyunsaturated long chain fatty acids in the phospholipid fraction is associated with an altered membrane associated proteome and these may be critical events in the metabolic remodelling induced by EPA treatment.

Keywords
cell signalling; fish oil; fatty acid; insulin; lipidomics; lipids

Journal
American Journal of Physiology - Endocrinology and Metabolism: Volume 314, Issue 6

StatusPublished
Author(s)Jeromson, Stewart; Mackenzie, Ivor; Doherty, Mary K; Whitfield, Phillip D; Bell, J Gordon; Dick, James R; Shaw, Andy; Rao, Francesco; Ashcroft, Stephen P; Philp, Andrew; Galloway, S D; Gallagher, Iain J; Hamilton, David Lee
FundersSociety for Endocrinology
Publication date30/06/2018
Publication date online27/06/2017
Date accepted by journal13/06/2017
URLhttp://hdl.handle.net/1893/25550
PublisherAmerican Physiological Society
ISSN0193-1849
Scroll back to the top